BioCentury
ARTICLE | Clinical News

Lenzilumab: Phase I started

August 8, 2016 7:00 AM UTC

KaloBios began an open-label, U.S. Phase I trial to evaluate 200, 400 and 600 mg IV lenzilumab twice monthly in up to 18 patients. ...